Table 1

Main subject characteristics

Age ≤50Age >50
Fenretinide (n = 30)Control (n = 30)Fenretinide (n = 30)Control (n = 30)
Age, years (mean ± SD)45.2 ± 4.044.3 ± 3.956.8 ± 4.559.6 ± 5.2
Pre/postmenopausal status28/230/04/262/28
Tumor stage: pT1/pT226/425/525/525/5
Quadrantectomy/mastectomy25/526/426/422/8
Ductal/lobular/other histology22/5/322/8/024/6/024/5/1
Years from diagnosis to randomization
 <1/1–3/>323/4/322/6/223/3/422/5/3